In newly diagnosed patients 75 years or older, or who have comorbidities that preclude the use of intensive induction chemotherapy.

*

INQOVI + venetoclax is

NOW APPROVED

for acute myeloid leukemia (AML)¹*

NOW APPROVED

Illustrative only. Not actual size. INQOVI tablets contain

decitabine and cedazuridine.

combination regimen for adults

with newly diagnosed AML^1,2

ALL-ORAL

The only

SEE THE DATA IN AML